Management of Type 2 Diabetes in Treatment-Naive Elderly Patients
Open Access
- 1 December 2007
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (12), 3017-3022
- https://doi.org/10.2337/dc07-1188
Abstract
OBJECTIVE—The purpose of this study was to evaluate the efficacy and safety of vildagliptin in elderly patients with type 2 diabetes.This publication has 21 references indexed in Scilit:
- Comparison between vildagliptin and metformin to sustain reductions in HbA1c over 1 year in drug‐naïve patients with Type 2 diabetesDiabetic Medicine, 2007
- Effects of Dipeptidyl Peptidase-4 Inhibition on Gastrointestinal Function, Meal Appearance, and Glucose Metabolism in Type 2 DiabetesDiabetes, 2007
- Vildagliptin in Drug-naïve Patients with Type 2 Diabetes: A 24-Week, Double-blind, Randomized, Placebo-controlled, Multiple-dose StudyHormone and Metabolic Research, 2007
- Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 DiabetesDiabetes Care, 2007
- Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2007
- Estimation of Glomerular Filtration Rate in Diabetic SubjectsDiabetes Care, 2005
- Management of Type 2 Diabetes Mellitus in the ElderlyDrugs & Aging, 2001
- The Effect of Age and Glycemic Level on the Response of the -Cell to Glucose-Dependent Insulinotropic Polypeptide and Peripheral Tissue Sensitivity to Endogenously Released InsulinJournal of Clinical Endocrinology & Metabolism, 1998
- Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy MenDiabetes Care, 1997
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987